MDT
84.21
+0.41%↑
VEEV
227.67
+3.34%↑
A
106.91
+1.84%↑
WBA
11.03
+0.46%↑
CHE
546.34
-6.7%↓
MDT
84.21
+0.41%↑
VEEV
227.67
+3.34%↑
A
106.91
+1.84%↑
WBA
11.03
+0.46%↑
CHE
546.34
-6.7%↓
MDT
84.21
+0.41%↑
VEEV
227.67
+3.34%↑
A
106.91
+1.84%↑
WBA
11.03
+0.46%↑
CHE
546.34
-6.7%↓
MDT
84.21
+0.41%↑
VEEV
227.67
+3.34%↑
A
106.91
+1.84%↑
WBA
11.03
+0.46%↑
CHE
546.34
-6.7%↓
MDT
84.21
+0.41%↑
VEEV
227.67
+3.34%↑
A
106.91
+1.84%↑
WBA
11.03
+0.46%↑
CHE
546.34
-6.7%↓
24h
Current
Min
7.08
Max
7.58
Income | -41M -65M |
---|---|
Profit margin | -82.56 |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +77.95% upside |
Next Earnings | 7 May 2025 |
---|
Past performance is not a reliable indicator of future results.
31 Dec 2024, 19:15 UTC
Verastem Shares Soar on FDA Priority Review of Cancer Treatment
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 12.67 USD 77.95%
High 20 USD
Low 8 USD
Based on 9 Wall Street analysts offering 12 month price targets forVerastem Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
9 ratings
9
Buy
0
Hold
0
Sell
Based on 9 analysts giving stock ratings to Verastem Inc - Dist in the past 3 months.
Selling and administration expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$